Press Releases

Research Papers

Events Calendar

Today
Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
American Academy of Pediatrics Virtual National Conference & Exhibition
American Academy of Pediatrics Virtual National Conference & Exhibition
2020-10-02 - 2020-10-05    
12:00 am
Organized by the American Academy of Pediatrics Experience education wherever you are, whenever you’d like with over 150 on-demand sessions and more than 35 live [...]
More Info
16th World Congress on Public Health 2020
16th World Congress on Public Health 2020
2020-10-12 - 2020-10-16    
12:00 am
Organized by Multiple Partners or Sponsors The global public health community will be meeting at a critical time for our planet. Global temperatures lie far [...]
More Info
BARDA Industry Day
BARDA Industry Day
2020-10-27    
12:00 am
Organized by BARDA BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA [...]
More Info
Events on 2020-10-02
American Academy of Pediatrics Virtual National Conference & Exhibition
2 Oct 20
Events on 2020-10-12
16th World Congress on Public Health 2020
12 Oct 20
Events on 2020-10-27
BARDA Industry Day
27 Oct 20
Speciality Care Services
June 17, 2014
Read More

Institute for Advanced Psychiatry

t the Institute of Advanced Psychiatry, we offer an integrative approach to our patients, including Deep Transcranial Magnetic Stimulation (Deep TMS, Brainsway), Ketamine infusions, medication , treatment of addiction to opioids (narcotics), brain Music Therapy and psychotherapy.

We focus on patients with severe and treatment resistant depression needing a new hope.

We are providing Deep Transcranial Magnetic Stimulation (Deep TMS, Brainsway) for the treatment of resistant major depression.

Deep TMS is a novel, FDA approved treatment for MDD. The magnetic coil stimulates deeper within the brain than rTMS and has been associated with a response rate of 75% and a remission rate of 35% in real life studies. Deep TMS is efficient even where multiple medications regimens have previously failed. Special protocols (some of them not FDA approved ) are available even for patients where standard TMS failed.

Details